Related Experiment Video
Updated: Feb 23, 2026
04:33
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
1.6K
Insomnia in tension-type headache: a population-based study.
Jiyoung Kim1, Soo-Jin Cho2, Won-Joo Kim3
1Department of Neurology, Bio Medical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
The Journal of Headache and Pain
|September 14, 2017
Summary
Insomnia is common in tension-type headache (TTH) patients and linked to worse headache symptoms and mental health. Identifying insomnia in TTH is key for better patient management.
Area of Science:
- Neurology
- Sleep Medicine
- Psychiatry
Background:
- Tension-type headache (TTH) is the most prevalent headache disorder.
- Severe TTH can be associated with psychiatric comorbidities and sleep disturbances.
- Population-based data on insomnia prevalence and impact in TTH patients are limited.
Purpose of the Study:
- To determine the prevalence of insomnia among individuals with TTH.
- To investigate the impact of insomnia on headache characteristics and psychiatric comorbidities in TTH patients.
- To analyze data from the Korean Headache-Sleep Study (KHSS).
Main Methods:
- A nationwide, cross-sectional, population-based survey (KHSS) of Korean adults (19-69 years).
- Insomnia was defined using the Insomnia Severity Index (ISI) score ≥ 10.
- Analysis included TTH diagnosis, insomnia status, and associated clinical factors.
Main Results:
- Insomnia prevalence was significantly higher in TTH patients (13.2%) compared to those without headache (5.8%).
- Among TTH patients, insomnia was associated with increased headache frequency, intensity, and impact.
- Insomnia in TTH patients correlated with higher rates of anxiety and depression.
Conclusions:
- Insomnia is a prevalent condition among individuals diagnosed with TTH.
- Insomnia exacerbates headache symptoms and is linked to psychiatric comorbidities in TTH.
- Screening for insomnia is crucial for effective TTH management.
Related Concept Videos
01:27Insomnia
512
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
512
01:19Management of Insomnia
732
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
732
01:24Substance Use Disorders Affecting Sleep
468
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
468
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
682
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
682
01:13Insufficient Sleep and Sleep Deprivation
977
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
977
01:07Narcolepsy
609
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
609